WO2007047189A3 - Targeted biocides - Google Patents
Targeted biocides Download PDFInfo
- Publication number
- WO2007047189A3 WO2007047189A3 PCT/US2006/039361 US2006039361W WO2007047189A3 WO 2007047189 A3 WO2007047189 A3 WO 2007047189A3 US 2006039361 W US2006039361 W US 2006039361W WO 2007047189 A3 WO2007047189 A3 WO 2007047189A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- relates
- present
- biocide
- fusion protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/12—Immunoglobulins specific features characterized by their source of isolation or production isolated from milk
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2006303998A AU2006303998A1 (en) | 2005-10-11 | 2006-10-10 | Targeted biocides |
CA002625580A CA2625580A1 (en) | 2005-10-11 | 2006-10-10 | Targeted biocides |
EP06825629A EP1933874A4 (en) | 2005-10-11 | 2006-10-10 | Targeted biocides |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72518005P | 2005-10-11 | 2005-10-11 | |
US60/725,180 | 2005-10-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007047189A2 WO2007047189A2 (en) | 2007-04-26 |
WO2007047189A3 true WO2007047189A3 (en) | 2007-11-15 |
Family
ID=37963026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/039361 WO2007047189A2 (en) | 2005-10-11 | 2006-10-10 | Targeted biocides |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1933874A4 (en) |
AU (1) | AU2006303998A1 (en) |
CA (1) | CA2625580A1 (en) |
WO (1) | WO2007047189A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8703134B2 (en) | 2003-05-15 | 2014-04-22 | Iogenetics, Llc | Targeted cryptosporidium biocides |
US8394379B2 (en) | 2003-05-15 | 2013-03-12 | Iogenetics, Llc | Targeted cryptosporidium biocides |
WO2012102679A1 (en) | 2011-01-24 | 2012-08-02 | National University Of Singapore | Pathogenic mycobacteria-derived mannose-capped lipoarabinomannan antigen binding proteins |
CN109942693B (en) * | 2019-04-03 | 2020-12-25 | 周口师范学院 | CTL epitope polypeptide of cryptosporidium parvum, application thereof and vaccine |
CN113455394B (en) * | 2021-07-23 | 2023-06-20 | 中国热带农业科学院橡胶研究所 | Standardized production method for large-scale breeding of rubber tree body embryo seedlings |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040009167A1 (en) * | 2002-02-07 | 2004-01-15 | Massachusetts Institute Of Technology | Anti-pathogen treatments |
US20050014932A1 (en) * | 2003-05-15 | 2005-01-20 | Iogenetics, Llc | Targeted biocides |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6015882A (en) * | 1992-05-29 | 2000-01-18 | The Regents Of The University Of California | Vaccines, antibodies, proteins, glycoproteins, DNAs and RNAs for prophylaxis and treatment of Cryptosporidium parvum infections |
EP0961547A4 (en) * | 1996-08-23 | 2002-08-14 | Univ North Carolina State | Neutralization-sensitive epitopes of cryptosporidium parvum |
EP1567868A4 (en) * | 2002-12-02 | 2008-02-06 | Biosynexus Inc | Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
WO2005040201A1 (en) * | 2003-10-21 | 2005-05-06 | The Regents Of The University Of California | Human cathelicidin antimicrobial peptides |
AU2005332655A1 (en) * | 2004-10-20 | 2006-12-14 | Iogenetics, Llc | Biocides |
-
2006
- 2006-10-10 EP EP06825629A patent/EP1933874A4/en not_active Withdrawn
- 2006-10-10 CA CA002625580A patent/CA2625580A1/en not_active Abandoned
- 2006-10-10 WO PCT/US2006/039361 patent/WO2007047189A2/en active Application Filing
- 2006-10-10 AU AU2006303998A patent/AU2006303998A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040009167A1 (en) * | 2002-02-07 | 2004-01-15 | Massachusetts Institute Of Technology | Anti-pathogen treatments |
US20050014932A1 (en) * | 2003-05-15 | 2005-01-20 | Iogenetics, Llc | Targeted biocides |
Non-Patent Citations (3)
Title |
---|
OREN ET AL.: "Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity", BIOCHEM. J., vol. 341, no. PART 3, 1 August 1999 (1999-08-01), pages 501 - 513, XP001091195 * |
PERRYMAN ET AL.: "Kinetics of Cryptosporidium parvum Sporozolla Neutrilization by Monoclonal Antibodies", INFECT. IMMUN., vol. 58, no. 1, January 1990 (1990-01-01), pages 257 - 259, XP000941233 * |
See also references of EP1933874A4 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007047189A2 (en) | 2007-04-26 |
CA2625580A1 (en) | 2007-04-26 |
EP1933874A4 (en) | 2010-03-03 |
AU2006303998A1 (en) | 2007-04-26 |
EP1933874A2 (en) | 2008-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004110143A3 (en) | Targeted biocides | |
Bertolini et al. | The transgenic animal platform for biopharmaceutical production | |
Belookov et al. | Using of EM-technology (effective microorganism) for increasing the productivity of calves | |
CN106243219B (en) | The single-chain antibody and preparation method thereof of one boar source property porcine epidemic diarrhea resisting virus | |
DK1765094T3 (en) | Product of hydrolyzed marine protein, process for its preparation and use | |
WO2007047189A3 (en) | Targeted biocides | |
PH12020500149A1 (en) | Efficient production of pichia yeasts and their use for enhancing plant and animal health | |
Verma et al. | In-vitro assessment of antioxidant and antimicrobial activity of whole porcine-liver hydrolysates and its fractions | |
Swift et al. | Thermophile lytic enzyme fusion proteins that target Clostridium perfringens | |
EA201391444A1 (en) | OPTION OF INSECTICIDAL AXMI GENE AND METHODS OF ITS APPLICATION | |
Lisovitskaya et al. | New standards governing the production of pork for children nutrition | |
Tseng et al. | Hepcidin-expressing fish eggs as a novel food supplement to modulate immunity against pathogenic infection in zebrafish (Danio rerio) | |
Pogodaev et al. | Economic-useful and biological features of Dorper Breeds into adaptation period to arid conditions the South of Russia | |
MX357713B (en) | NOVEL INSECTICIDAL PROTEINS and METHODS FOR THEIR USE. | |
MX2017011525A (en) | Insecticidal combinations of pip-72 and methods of use. | |
Asaye et al. | Genetic engineering in animal production: Applications and prospects | |
CN106754849A (en) | A kind of multi-functional lyases and its preparation method and application | |
Singh et al. | Steps Toward Sustainable Livestock Development: Technologies to Boost Indigenous Livestock | |
CN106967740B (en) | Escherichia coli fusion expression plectasin, preparation method and application thereof | |
Stepanova | Application of probiotics in poultry farming | |
CN102433314A (en) | Recombinant fenneropenaeus merguiensis lysozyme, as well as preparation and application thereof | |
Khan | Introduction to Biotechnology | |
Tonukari et al. | Diverse applications of biotechnology | |
Sukara et al. | Agricultural biotechnology in Indonesia | |
Aslam et al. | An Overview: Current Revolutions in the Field of Genetic Engineering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006825629 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2625580 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 567418 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006303998 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2006303998 Country of ref document: AU Date of ref document: 20061010 Kind code of ref document: A |